MI HB 4878

• Health: pharmaceuticals
• State agencies (existing): attorney general
• State agencies (existing): licensing and regulatory affairs

• Curtis VanderWallprimary

Not provided by source.

1. 2025-09-11

   introduced by Representative Rep. Curtis VanderWall

   introduction

2. 2025-09-11

   read a first time

   reading-1

3. 2025-09-11

   referred to Committee on Health Policy

   referral-committee

4. 2025-09-16

   bill electronically reproduced 09/11/2025

5. 2026-01-28

   reported with recommendation for referral to Committee on Rules with substitute (H-3)

   committee-passage

6. 2026-01-28

   recommendation concurred in

• House Introduced BillCompare
• Substitute (H-3)Compare
• (document, no version)Compare

• application/pdf(no extracted text yet)
• text/html(no extracted text yet)
• text/html
• application/pdf(no extracted text yet)

Not provided by source.

No related bills recorded for this bill.

Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:27.556085Z

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MI&identifier=HB 4878. See the API docs or the MCP server for AI assistants.

• Sponsor party and chamber affiliation are not yet captured by this API.
• Committee referrals are not yet captured.
• Some documents have no extracted text yet, so version comparison may be limited.